NCT00310323View on ClinicalTrials.gov

Hepatic Drug Biotransformation in Children With Obstructive Sleep Apnea

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Sleep Apnea
Interventions
DRUG

Dextromethorphan

0.5 mg/kg (maximum 30 mg)

DRUG

Caffeine

Administered as 4 ounces of Coca-Cola

Trial Locations (2)

23298

Virginia Commonwealth University, Richmond

40202

University of Louisville, Louisville

All Listed Sponsors
collaborator

University of Louisville

OTHER

lead

Virginia Commonwealth University

OTHER

NCT00310323 - Hepatic Drug Biotransformation in Children With Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter